$0.962
-0.058[-5.69%]
At close: May 13
$0.962
0[0.00%]
PreMarket: 5:23AM EDT
Seres Therapeutics
(NASDAQ:MCRB)Latest News for Seres Therapeutics Stock (NASDAQ:MCRB)
Seres Therapeutics Stock (NASDAQ: MCRB)
Categories: All
Thursday, May 09, 2024
Wednesday, May 08, 2024
- Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionAvi Kapoor - 4 days ago
- Seres Therapeutics shares are trading lower after the company reported Q1 financial results.Benzinga Newsdesk - 4 days ago
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - 4 days ago
- Nasdaq Down Over 50 Points; Uber Posts Q1 LossAvi Kapoor - 4 days ago
- Seres Therapeutics' Q1 Cash And Cash Equivalents Of $111.2M Is Expected To Provide Cash Runway Into Q4 Of 2024Benzinga Newsdesk - 4 days ago
- Seres Therapeutics Q1 2024 GAAP EPS $(0.27) Beats $(0.34) EstimateBenzinga Newsdesk - 4 days ago
Wednesday, March 06, 2024
- Oppenheimer Maintains Outperform on Seres Therapeutics, Lowers Price Target to $5Benzinga Newsdesk - Mar 6, 2024, 8:59AM
- Emerson Electric To Rally More Than 19%? Here Are 10 Top Analyst Forecasts For WednesdayAvi Kapoor - Mar 6, 2024, 8:00AM
- Chardan Capital Maintains Buy on Seres Therapeutics, Lowers Price Target to $8Benzinga Newsdesk - Mar 6, 2024, 7:38AM
Tuesday, March 05, 2024
- Seres' $128M In Cash Balance, Planned Savings From Restructuring Announced In November 2023, And, Assuming Continued Revenue Growth Of Vowst, Expected Receipt Of The $45M Tranche B Under Its Secured Debt Will Support Its Operations Into Q4 2024Benzinga Newsdesk - Mar 5, 2024, 7:07AM
- Seres Therapeutics FY GAAP EPS $(0.89) Beats $(0.96) Estimate, Sales $126.33M Beat $126.07M EstimateBenzinga Newsdesk - Mar 5, 2024, 7:04AM
- Earnings Scheduled For March 5, 2024Benzinga Insights - Mar 5, 2024, 5:00AM
Monday, March 04, 2024
Monday, February 26, 2024
Wednesday, January 17, 2024
Tuesday, January 16, 2024
Tuesday, January 09, 2024
- Why Is Microbiome-Based Seres Therapeutics Stock Trading Higher Today?Vandana Singh - Jan 9, 2024, 12:12PM
- Dow Tumbles Over 200 Points; US Trade Gap Narrows In NovemberAvi Kapoor - Jan 9, 2024, 9:40AM
- Seres Therapeutics shares are trading higher after the company announced preliminary key VOWST launch metrics and FDA Fast Track Designation for SER-155.Benzinga Newsdesk - Jan 9, 2024, 9:08AM
- Market-Moving News for January 9thBenzinga Newsdesk - Jan 9, 2024, 8:38AM
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga Insights - Jan 9, 2024, 8:06AM
- Seres Therapeutics Receives FDA Fast Track Designation For SER-155, Cultivated Microbiome Therapeutic Designed To Prevent GI-associated Bacterial InfectionsBenzinga Newsdesk - Jan 9, 2024, 7:14AM
- Seres Therapeutics Announces Vowst Preliminary Net Sales Of Approximately $10.4M (Unaudited) For Q4 Of 2023, Total 2023 Net Sales Since Launch In June Were Approximately $19.6M And Reflected A Gross-to-net Reduction Of 13%Benzinga Newsdesk - Jan 9, 2024, 7:11AM
Friday, December 08, 2023
Monday, November 20, 2023
Friday, November 03, 2023
- Why Fortinet Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Friday's Mid-Day SessionLisa Levin - Nov 3, 2023, 1:26PM
- Goldman Sachs Maintains Sell on Seres Therapeutics, Lowers Price Target to $1.25Benzinga Newsdesk - Nov 3, 2023, 10:58AM
- Nasdaq Gains 1%; US Adds 150,000 Jobs In OctoberLisa Levin - Nov 3, 2023, 10:02AM
Thursday, November 02, 2023
- Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionLisa Levin - Nov 2, 2023, 2:26PM
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - Nov 2, 2023, 1:31PM
- Seres Therapeutics Q3 2023 $(0.37) Beats $(0.50) EstimateBenzinga Newsdesk - Nov 2, 2023, 7:03AM
- Earnings Scheduled For November 2, 2023Benzinga Insights - Nov 2, 2023, 4:56AM